concept

SWI

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SWI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

51Connections
24Hypotheses
0Analyses
14Outgoing
37Incoming
11Experiments
0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameSWI
Key Genes/ProteinsADNP, ASC, ATG, BACE1, BECN1, BRG1
Related Diseasesautism spectrum disorder, cancer
Related Pathwaysautophagy pathway
Linked Hypotheses1 hypotheses

Wiki Pages (3)

Knowledge base pages for this entity

Canonical Page

TDP-43 PET Ligand Development for Frontotemporal Dementia

gap · 1202 words

SIN3A Protein — SWI-Independent 3A Transcriptional Regulator

protein · 2130 words

SMARCB1 — SWI/SNF Related Matrix Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1

gene · 1352 words

Pathway Diagram

graph TD
    SWI[SWI]
    SWI -->|activates| TNF[TNF]
    SWI -->|activates| TNFA[TNFA]
    SWI -->|activates| ULK1[ULK1]
    SWI -->|activates| cancer[cancer]
    SWI -->|causes| VHL[VHL]
    SWI -->|participates in| autophagy_pathway[autophagy pathway]
    SWI -->|participates in| oxidative_stress_response[oxidative stress response]
    SWI -->|participates in| necroptosis[necroptosis]
    SWI -->|participates in| MAPK_signaling[MAPK signaling]
    SNF[SNF] -->|interacts| SWI
    ASC[ASC] -->|activates| SWI
    BECN1[BECN1] -->|activates| SWI
    BRG1[BRG1] -->|activates| SWI
    CLDN2[CLDN2] -->|activates| SWI
    ERN1[ERN1] -->|activates| SWI
    IRGM1[IRGM1] -->|activates| SWI
    LC3[LC3] -->|activates| SWI
    MELK[MELK] -->|activates| SWI
    MTOR[MTOR] -->|activates| SWI

Outgoing (14)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:SWIdata_indataset_row0.00
TNFAactivatesgene0.60
ULK1activatesgene0.60
TNFactivatesgene0.60
autism spectrum disorderinteracts_withdisease0.60

Incoming (37)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:SWIdata_indataset_row0.00
SNFinteracts_withgene0.70
ROSactivatesgene0.60
BACE1associated_withgene0.60
SNFcausesgene0.60

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
miR-155/Interferon-gamma Feedback Loop as a Reversible Molec 0.843 neurodegeneration How do different microglial subtypes (DA
HDL/apoE Particle Remodeling as a Therapeutic Switch for CAA 0.766 neurodegeneration What molecular mechanisms explain how ap
Tau/MAP6 ratio as a master switch for microtubule dynamics p 0.750 neurodegeneration View
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Metabolic Switch Targeting for A1→A2 Repolarization 0.726 neurodegeneration Astrocyte reactivity subtypes in neurode
TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects S 0.708 synaptic biology Does SPP1-mediated synaptic engulfment r
TREM2 haploinsufficiency dysregulates microglial synaptic su 0.700 neurodegeneration Synaptic pruning by microglia in neurode
Temporal Microglial State Switching 0.695 - Neuroinflammation and microglial priming
Endothelial NRF2 Activation as a Master Switch for Post-CA B 0.689 neurodegeneration View
Lipid Droplet Dynamics as Phenotype Switches 0.666 neurodegeneration Astrocyte reactivity subtypes in neurode
Complement C1q Subtype Switching 0.665 neurodegeneration 4R-tau strain-specific spreading pattern
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A 0.664 neurodegeneration RNA binding protein dysregulation across
H7: Aberrant RNA Template Switching Converts Granules to Agg 0.625 neurodegeneration How do pathological stress granules tran
Conditional CRISPR Kill Switches for Aberrant Protein Cleara 0.624 neurodegeneration CRISPR-based therapeutic approaches for
Ketone-Based Metabolic Switching to Restore PV Interneuron F 0.609 neurodegeneration test
Calmodulin isoform switching from CaMK to calcineurin activa 0.607 neurodegeneration What determines the specificity of calci
Dynamic Microglial Phenotype Switching Biomarker Panel for N 0.577 neurodegeneration What amyloid threshold level is required
REST Complex Dysregulation as Master Epigenetic Switch 0.570 neurodegeneration Comparative epigenetic signatures: DNA m
Glucose-Ketone Metabolic Switch Timing 0.531 metabolic neuroscience What determines the optimal timing and d
Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes 0.530 neurodegeneration Comparative epigenetic signatures: DNA m
Calcineurin-FUNDC1 Axis as a Master Switch for Mitophagy vs. 0.430 neurodegeneration What determines organelle-specific autop
CK2-mediated HSP90α phosphorylation switches client discrimi 0.410 protein biochemistry Do chaperones selectively recognize path
Partial Agonist/SPP1 Splice Variant Strategy: Splice-Switchi 0.375 synaptic biology Does SPP1-mediated synaptic engulfment r
RGS6 isoform switching or small-molecule RGS6 activation as 0.220 neurodegeneration Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (11)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
ABCA1 rs2230806 polymorphism association with dementia risk in hyperli exploratory dementia, Alzheimer's disease 0.900 0.00 human patients proposed N/A
Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an falsification Neurodegeneration 0.400 0.50 cell_line proposed $100,000
Proposed experiment from debate on Microglia activate astrocytes via I falsification Neuroinflammation 0.400 0.50 cell_line proposed $80,000
Metabolic Pathway-Targeted Therapy in ALS clinical ALS 0.400 0.50 human proposed $6,550,000
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Cytochrome Therapeutics clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Peroxisomal Dysfunction Validation in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,280,000
Peroxisome Dysfunction Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352] Pesce NA, Seminara G, Giarrusso G, Tomas Adv Biol (Weinh) 2026 1
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285] Fang M, Zhou Y, He K, Lu Y, Tao F, Huang Mol Neurobiol 2025 1
Hexokinase 2-mediated metabolic stress and inflammation burden of liver macropha [PMID:40014451] Li J, Chen X, Song S, Jiang W, Geng T, W Cell Rep 2025 1
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014] Fontana F, Giannitti G, Marchesi S, Limo Int J Biol Sci 2024 1
Inhibition of sterol O-acyltransferase 1 blocks Zika virus infection in cell lin [PMID:39237833] Schöbel A, Pinho Dos Reis V, Burkhard R, Commun Biol 2024 1
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage. [PMID:36009491] Kou Y, Geng F, Guo D Biomedicines 2022 1
Lipid Stores and Lipid Metabolism Associated Gene Expression in Porcine and Bovi [PMID:32899450] Kajdasz A, Warzych E, Derebecka N, Madej Int J Mol Sci 2020 1
Metabolic phenotype of bladder cancer. [PMID:26975021] Massari F, Ciccarese C, Santoni M, Iacov Cancer Treat Rev 2016 1
Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration a [PMID:41546868] ["Tabor G", "Litvinchuk A", "Chen Y", "A Cell reports 2026 0
Neuroprotective Effects of Berberine Chloride Against the Aluminium Chloride-Ind [PMID:40014257] Uvarajan D, Gnanarajan R, Karuppusamy PA Mol Biotechnol 2026 0
Aryl hydrocarbon receptor impairs HK2-controlled flux of the hexosamine biosynth [PMID:40582563] Li S, Zhu J, Song J, Yang L, Gong Y et a J Adv Res 2026 0
Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] Albrechtsen HM, Saritas G, Winge SB, Mai J Clin Endocrinol Metab 2026 0
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis [PMID:41023273] Mitchell CD, Morris CA, Wild M, Cunningh Acta Pharmacol Sin 2026 0
Hypoxia-Induced Histone Lactylation Promotes Ferroptosis in Cardiomyocytes via t [PMID:41229334] Zhu XH, Hou JW, Lv ZY, Sun MH, Zhang XY Kaohsiung J Med Sci 2026 0
Epigenetics in chronic rhinosinusitis. [PMID:41442742] Kumar N, Brar T, Lal D Curr Opin Otolaryngol Head Nec 2026 0
Granzyme B knockdown inhibits NLRP3-mediated pyroptosis and the JAK2/STAT3 signa [PMID:41447776] Wang M, Chen D, Zhang D, Han H, Xie M et Tissue Cell 2026 0
Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell-D [PMID:41503702] Kim J, Park D, Yoo J, Kim JE, Kim EH et Stroke 2026 0
Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic ad [PMID:41548699] Zhang J, Zhang T, Song D, Xu D Biochim Biophys Acta Rev Cance 2026 0
Interplay between cholesterol, Bis(monoacylglycerol)phosphate, and parasitophoro [PMID:41747887] Hennot C, Leroux M, Lambert R, Boukherro Biochimie 2026 0
Integrated Bioinformatics Analysis of a TF-miRNA-mRNA Regulatory Network in Reti [PMID:41755728] Liang C, Xie H, Shi Q, Diao Y, Yu G et a Curr Eye Res 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SWI in their description or question text

TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from D

Score: 0.708 · synaptic biology · 2026-04-21

## Mechanistic Overview TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Re

TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switchin

Score: 0.700 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The triggering receptor expressed on myeloid cells 2 (TREM2) functions as a criti

Temporal Microglial State Switching

Score: 0.695 · unknown disease · 2026-04-04

## Mechanistic Overview Temporal Microglial State Switching starts from the claim that modulating Optogenetic constructs

Endothelial NRF2 Activation as a Master Switch for Post-CA BBB Protection

Score: 0.689 · neurodegeneration · 2026-04-17

## Mechanistic Overview Endothelial NRF2 Activation as a Master Switch for Post-CA BBB Protection starts from the claim

Lipid Droplet Dynamics as Phenotype Switches

Score: 0.666 · neurodegeneration · 2026-04-02

## Mechanistic Overview Lipid Droplet Dynamics as Phenotype Switches starts from the claim that modulating DGAT1 and SOA

Complement C1q Subtype Switching

Score: 0.665 · neurodegeneration · 2026-04-02

## Mechanistic Overview Complement C1q Subtype Switching starts from the claim that modulating C1QA within the disease c

Stathmin-2 Splice Switching to Prevent Axonal Degeneration Across the ALS-FTD-AD

Score: 0.664 · neurodegeneration · 2026-04-13

**Molecular Mechanism and Rationale** The stathmin-2 splice switching therapeutic approach targets a fundamental pathom

H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone

Score: 0.625 · neurodegeneration · 2026-04-22

## Mechanistic Overview H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone starts from the claim

Conditional CRISPR Kill Switches for Aberrant Protein Clearance

Score: 0.624 · neurodegeneration · 2026-04-04

## Mechanistic Overview Conditional CRISPR Kill Switches for Aberrant Protein Clearance starts from the claim that modul

Ketone-Based Metabolic Switching to Restore PV Interneuron Function

Score: 0.609 · neurodegeneration · 2026-04-16

## Mechanistic Overview Ketone-Based Metabolic Switching to Restore PV Interneuron Function starts from the claim that m

Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal

Score: 0.607 · neurodegeneration · 2026-04-21

## Mechanistic Overview Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal permeabilization

Dynamic Microglial Phenotype Switching Biomarker Panel for Neuroinflammatory Tre

Score: 0.577 · neurodegeneration · 2026-04-20

**Molecular Mechanism and Rationale** The molecular foundation of this biomarker panel centers on the intricate interpl

REST Complex Dysregulation as Master Epigenetic Switch

Score: 0.570 · neurodegeneration · 2026-04-25

REST Complex Dysregulation as Master Epigenetic Switch

Glucose-Ketone Metabolic Switch Timing

Score: 0.531 · metabolic neuroscience · 2026-04-16

## Mechanistic Overview Glucose-Ketone Metabolic Switch Timing starts from the claim that modulating GLUT1/GLUT3/MCT1/MC

Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes

Score: 0.530 · neurodegeneration · 2026-04-25

Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes